Colorectal Cancer

As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.

The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy.

Receiving a diagnosis of colon cancer at age 34 was such a shocking experience, but it has helped me become more strong-willed.

Even after a personal connection to cancer, oncology nurse Megan has embraced the cancer space as her passion.

Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors.

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

MRIs were able to predict organ preservation and survival with the “watch-and-wait” approach in patients with rectal cancer.

When my grandmother passed away one Thanksgiving after my colon cancer diagnosis, I realized how grateful I am for her life and my own as a survivor.

The FDA approved several drugs throughout November for the treatment of diseases including leukemia and biliary tract cancer, in addition to a diagnostic for solid cancers.

With stage 4 colon cancer, I still think about death, but I’ve learned how to live in the present to enjoy each day I have.

From the deaths of actor Paul Teal and Chicago Bulls player Bob Love to a contestant on “Jeopardy!” revealing his colon cancer diagnosis, here’s what’s happening in the oncology space this week.

With Thanksgiving coming soon, I find that November is the perfect time to reflect and gather feelings of gratitude as a cancer survivor.

RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more research is necessary.

When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, I had to keep working hard for it.

An expert explains how attitudes towards lymphedema risk have evolved over the years.

Ponsegromab helped patients with cachexia and elevated GDF-15 levels gain weight, increase activity and improve cachexia symptoms, with manageable safety.

MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from treatment with targeted therapies.

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.

Rates of colorectal cancer diagnoses and deaths are climbing among patients younger than 55, researchers have shown.

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

I initially put off a colonoscopy due to gastroesophageal reflux disease, but after a positive home screening test, I underwent the procedure and was diagnosed with stage 3 rectal cancer.

Carla Deschamps shares her experience with colon cancer and how her brother, sisters and parents helped her through the journey.

As many of us have experienced, the COVID-19 pandemic affected our lives. But at the beginning, I was receiving treatment for cancer.

Distance relapse-free survival was maintained in patients with pMMR locally advanced rectal cancer through non-operative management of the disease.

I invited my family to gather with me and celebrate four years of being cancer-free.

From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.

Before receiving my colorectal cancer diagnosis, I had experienced cancer. However, my depression felt different during treatment.

In patients with BRAF V600E-mutant metastatic colorectal cancer, a combination of Braftovi, Erbitux and chemotherapy showed promising antitumor activity.

Patients with metastatic disease whose cancers were tested and treated for specific mutations tended to have better outcomes than those given the standard of care.